Media About Us


  • 25 July 2012

    Venture capital spurs Russian drug development  in California

    Venture capital spurs Russian drug development in California

    Isabel Gorst, FT-Beyondbrics

    When the Kremlin invited a group of US venture capitalists to Russia during the financial crisis, some of the visitors saw as much an opportunity to scout for fresh sources of capital as they did a new place to invest in.

  • 25 July 2012

    Rusnano and Domain Associates announce first joint investment

    Rusnano and Domain Associates announce first joint investment

    Nano werk

    RusnanoMedInvest (RMI, a portfolio company of RUSNANO) and Domain Associates, the Princeton, NJ- and San Diego, CA-based venture capital firm today announced their first investment under a joint agreement reached in March. The two will jointly invest nearly $40 million in San Diego, CA-based, CoDa Therapeutics, a Domain portfolio company, along with current investors GBS Ventures (Melbourne, Australia) and BioPacificVentures (Auckland, NZ).

  • 25 July 2012

    Coda Therapeutics raise additional $20M for series B

    Private Equity Hub

    CoDa Therapeutics has raised an additional $20 million from RusnanoMedInvest in a second close of its Series B financing round. This brings the total Series B Round to nearly $40 million following the first close late last year. All current investors, including Domain Associates, GBS Ventures and BioPacificVentures participated. San Diego-based CoDa is a biopharmaceutical company working to develop drug therapies for wounds that do not heal properly, including venous leg and diabetic foot ulcers.

  • 24 July 2012

    Russias Rusnano, Domain Invest $40 Million In San Diegos CoDa

    Russias Rusnano, Domain Invest $40 Million In San Diegos CoDa

    Ksenia Galouchko, Bloomberg

    Russian Nanotechnologies, the state- run technology holding, and Domain Associates, a U.S. venture fund, are investing about $40 million in San Diego-based biopharmaceutical company CoDa Therapeutics.

  • 07 March 2012

    RUSNANO and Domain to Collaborate on Investments in Health Sciences Projects

    RUSNANO and Domain to Collaborate on Investments in Health Sciences Projects

    Nanowerk News

    RUSNANO and Domain Associates, a U.S. venture capital firm specializing in leading-edge life sciences technologies, today announced a partnership that will spur modernization of the Russian healthcare market by bringing next-generation pharmaceuticals, medical devices and diagnostics to Russia.

  • 06 March 2012

    Domain partners with RusNano on $760M biotech investment plan

    Domain partners with RusNano on $760M biotech investment plan

    John Carroll, Fierce Biotech

    The Russians are back. After capturing the attention of the nanobio crowd with a few hefty investments in the U.S., RusNano is now partnering with Domain Associates on a $760 million initiative that will invest in about 20 life sciences companies and construct a pharma manufacturing center in Russia to produce next-gen therapies.

  • 06 March 2012

    Rusnano Teams Up With U.S. Fund Domain to Invest in Life Science

    Rusnano Teams Up With U.S. Fund Domain to Invest in Life Science

    Jason Corcoran, BLOOMBERG

    Russian Nanotechnologies Corp. plans to work with Domain Associates, a U.S. venture fund, to invest $760 million in U.S. life science companies and build facilities in Russia.